Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Comparative evaluation of ketoconazole-β-cyclodextrin systems prepared by coprecipitation and kneading.

Marzouk MA, Kassem AA, Samy AM, Amer RI.

Drug Discov Ther. 2010 Oct;4(5):380-7.

2.

Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.

Badr-Eldin SM, Elkheshen SA, Ghorab MM.

Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.

PMID:
18655829
3.

Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.

Patel SG, Rajput SJ.

AAPS PharmSciTech. 2009;10(2):660-9. doi: 10.1208/s12249-009-9249-7. Epub 2009 May 21.

4.

Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.

Semcheddine F, Guissi Nel I, Liu X, Wu Z, Wang B.

AAPS PharmSciTech. 2015 Jun;16(3):704-15. doi: 10.1208/s12249-014-0257-x. Epub 2014 Dec 17.

5.

Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.

Semalty M, Panchpuri M, Singh D, Semalty A.

Curr Drug Discov Technol. 2014 Jun;11(2):154-61.

PMID:
24188445
6.

An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.

Bandarkar FS, Vavia PR.

Drug Dev Ind Pharm. 2011 Nov;37(11):1318-28. doi: 10.3109/03639045.2011.572285. Epub 2011 Apr 21.

PMID:
21506882
7.

Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.

Patel NV, Chotai NP, Patel MP.

Pharmazie. 2008 Apr;63(4):275-81.

PMID:
18468386
8.
9.

Effect of inclusion complexation with cyclodextrins on photostability of nifedipine in solid state.

Bayomi MA, Abanumay KA, Al-Angary AA.

Int J Pharm. 2002 Aug 28;243(1-2):107-17.

PMID:
12176299
10.

Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.

Lahiani-Skiba M, Barbot C, Bounoure F, Joudieh S, Skiba M.

Drug Dev Ind Pharm. 2006 Oct;32(9):1043-58.

PMID:
17012117
11.

Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.

Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P.

Drug Dev Ind Pharm. 2005 Aug;31(7):697-707.

PMID:
16207617
13.

Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.

Sbârcea L, Udrescu L, Drăgan L, Trandafirescu C, Szabadai Z, Bojiţă M.

Pharmazie. 2011 Aug;66(8):584-9.

PMID:
21901980
14.

Physico-chemical characterization in solution and in the solid state of clonazepam complexes with native and chemically-modified cyclodextrins.

Mennini N, Bragagni M, Maestrelli F, Mura P.

J Pharm Biomed Anal. 2014 Feb;89:142-9. doi: 10.1016/j.jpba.2013.11.009. Epub 2013 Nov 15.

PMID:
24291109
15.

Amorphous solid dispersion studies of camptothecin-cyclodextrin inclusion complexes in PEG 6000.

Fatmi S, Bournine L, Iguer-Ouada M, Lahiani-Skiba M, Bouchal F, Skiba M.

Acta Pol Pharm. 2015 Jan-Feb;72(1):179-92.

16.

Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.

Patel R, Purohit N.

AAPS PharmSciTech. 2009;10(4):1301-12. doi: 10.1208/s12249-009-9321-3. Epub 2009 Oct 29.

17.

Solubility and stability enhancement of atorvastatin by cyclodextrin complexation.

Palem CR, Patel S, Pokharkar VB.

PDA J Pharm Sci Technol. 2009 May-Jun;63(3):217-25.

PMID:
20069794
19.

Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.

Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.

Eur J Pharm Biopharm. 2007 Jun;66(3):413-21. Epub 2006 Nov 29.

PMID:
17240129
20.

Effect of auxiliary substances on complexation efficiency and intrinsic dissolution rate of gemfibrozil-beta-CD complexes.

Sami F, Philip B, Pathak K.

AAPS PharmSciTech. 2010 Mar;11(1):27-35. doi: 10.1208/s12249-009-9350-y. Epub 2009 Dec 15.

Items per page

Supplemental Content

Write to the Help Desk